- Home
- AMN vs GHRS Comparison
AMN vs GHRS Comparison
Compare AMN & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMN
- GHRS
- Stock Information
- Founded
- AMN 1985
- GHRS 2018
- Country
- AMN United States
- GHRS Ireland
- Employees
- AMN N/A
- GHRS N/A
- Industry
- AMN Assisted Living Services
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- AMN Health Care
- GHRS Health Care
- Exchange
- AMN Nasdaq
- GHRS Nasdaq
- Market Cap
- AMN 806.3M
- GHRS 774.1M
- IPO Year
- AMN 2001
- GHRS 2021
- Fundamental
- Price
- AMN $19.36
- GHRS $12.88
- Analyst Decision
- AMN Hold
- GHRS Strong Buy
- Analyst Count
- AMN 8
- GHRS 8
- Target Price
- AMN $23.25
- GHRS $30.63
- AVG Volume (30 Days)
- AMN 1.0M
- GHRS 194.6K
- Earning Date
- AMN 11-06-2025
- GHRS 11-13-2025
- Dividend Yield
- AMN N/A
- GHRS N/A
- EPS Growth
- AMN N/A
- GHRS N/A
- EPS
- AMN N/A
- GHRS N/A
- Revenue
- AMN $2,769,926,000.00
- GHRS N/A
- Revenue This Year
- AMN N/A
- GHRS N/A
- Revenue Next Year
- AMN N/A
- GHRS N/A
- P/E Ratio
- AMN N/A
- GHRS N/A
- Revenue Growth
- AMN N/A
- GHRS N/A
- 52 Week Low
- AMN $14.87
- GHRS $6.00
- 52 Week High
- AMN $48.49
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- AMN 48.82
- GHRS 47.00
- Support Level
- AMN $17.69
- GHRS $12.36
- Resistance Level
- AMN $19.88
- GHRS $13.37
- Average True Range (ATR)
- AMN 0.91
- GHRS 0.78
- MACD
- AMN -0.17
- GHRS -0.06
- Stochastic Oscillator
- AMN 47.18
- GHRS 38.04
About AMN AMN Healthcare Services Inc
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.